Palatable ductile chewable veterinary composition

Details for Australian Patent Application No. 2004262492 (hide)

Owner Novartis AG

Inventors Isele, Ute

Agent Davies Collison Cave

Pub. Number AU-B-2004262492

PCT Pub. Number WO2005/013714

Priority 03017252.2 30.07.03 EP

Filing date 29 July 2004

Wipo publication date 17 February 2005

Acceptance publication date 10 January 2008

International Classifications

A23K 1/00 (2006.01) Animal feeding-stuffs

A23K 1/16 (2006.01) Animal feeding-stuffs - supplemented with accessory food factors

A23K 1/17 (2006.01) Animal feeding-stuffs - with antibiotics

A23K 1/18 (2006.01) Animal feeding-stuffs - specially adapted for particular animals

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/013714 Priority application(s): WO2005/013714

10 January 2008 Application Accepted

  Published as AU-B-2004262492

24 April 2008 Opposition Lodged

  Mars, Incorporated has lodged an opposition against Novartis AG.

24 December 2009 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 30 Sep 2009. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000 2005

15 April 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 30 Sep 2009 2005

15 April 2010 Opposition Withdrawn

  The opposition by Mars, Incorporated against Novartis AG has been withdrawn.

20 May 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004262494-Means and methods for treating a disease which is associated with an excess transport of hyaluronan across a lipid bilayer

2004262491-2-`4-(hydroxymethyl-phenylamino) - piperidine-1-yl!-N- (9H-carbazol-3-yl) - acetamine derivatives and related compounds as neuropeptide Y5 (NPY5) ligands for the treatment of obesity